IHC showed that compared with the PBS control group, the Ad-VT, gemcitabine and paclitaxel treatment groups had decreased Ki-67 expression in lung cancer tissues and increased TUNEL staining (Fig. 6c). The gene discussed is MKI67; the disease is lung cancer.